Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaoduqing granules for constipation and gut microbiota in peritoneal dialysis patients
ChiCTR2300075189Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2023
- Countries
- 1
01
Overview
Phase 4, open-label trial of niaoduqing in constipation, end-stage kidney disease (ESKD) and uremia (3 arms), sponsored by Peking University People's Hospital. Primary endpoints: Effective rate of constipation treatment, Gut microbiota abundance and diversity and 1 more. Started Sep 2023; status: recruiting.
02
Drugs
niaoduqing
03
Conditions
constipationend-stage kidney disease (ESKD)uremia
Beyond the preview
Go deeper on ChiCTR2300075189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075189.